Cleared Traditional

SIDDHARTH-II (K222762) - FDA 510(k) Clearance

Also marketed or referenced as:
IMPACT

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2023
Decision
268d
Days
Class 2
Risk

K222762 is an FDA 510(k) clearance for the SIDDHARTH-II. Classified as Accelerator, Linear, Medical (product code IYE), Class II - Special Controls.

Submitted by Panacea Medical Technologies Pvt. , Ltd. (Malur, IN). The FDA issued a Cleared decision on June 8, 2023 after a review of 268 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Panacea Medical Technologies Pvt. , Ltd. devices

Submission Details

510(k) Number K222762 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 13, 2022
Decision Date June 08, 2023
Days to Decision 268 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
161d slower than avg
Panel avg: 107d · This submission: 268d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IYE Accelerator, Linear, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYE Accelerator, Linear, Medical

All 227
Devices cleared under the same product code (IYE) and FDA review panel - the closest regulatory comparables to K222762.
AccuCheck
K223834 · Manteia Technologies Co., Ltd. · Jul 2023
Radixact Treatment Delivery System
K223159 · Accuray Incorporated · Jun 2023
MapRT
K231185 · Vision Rt, Ltd. · Jun 2023
TrueBeam, TrueBeam STx, Edge, VitalBeam
K223839 · Varian Medical Systems, Inc. · May 2023
ExacTrac Dynamic 1.1.2
K231052 · Brainlab AG · May 2023
ARIA Radiation Therapy Management (v18.0)
K230699 · Varian Medical Systems, Inc. · Apr 2023